 Connection
Sarah Tevis to Breast Neoplasms
This is a "connection" page, showing publications Sarah Tevis has written about Breast Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
10.139 |
|
|
|
-
Adams M, Higgins MG, Vemuru SR, Huynh V, Coons HL, Baurle E, Rojas KE, Hampanda K, Zimmaro L, Arkema A, Bozzuto L, Fleagle E, Makela K, Singer K, Tevis SE. Developing a patient-centered educational video series on sexual health for women with breast cancer. Support Care Cancer. 2025 Jul 28; 33(8):724.
Score: 0.399
-
Bheemireddy S, Leslie SE, Durden JA, Burnet G, Aryanpour Z, Fong A, Higgins MG, Greenseid S, McLemore L, Li G, Miles R, Taft N, Tevis S. The Use of ChatGPT-4.0 to Simplify Breast Pathology Reports: A Study on Readability and Accuracy. Ann Surg Oncol. 2025 Oct; 32(11):8400-8408.
Score: 0.398
-
Jiang JG, Agarwal T, Higgins MG, Roy MK, Adams M, Leslie SE, Baurle E, Rojas KE, Tevis SE. Identifying resource needs of patients with breast cancer by examining alignment of Reddit post content with BREAST-Q domains. Am J Surg. 2025 Sep; 247:116486.
Score: 0.396
-
Higgins MG, Vemuru S, Helmkamp L, Adams M, Colborn K, Parris H, Huynh V, Christian N, Ahrendt G, Lee C, Kim S, Matlock D, Cumbler E, Tevis S. Access to results of patient reported outcome surveys did not improve longitudinal patient reported outcomes in breast cancer patients in a randomized controlled trial. Am J Surg. 2025 Jan; 239:116054.
Score: 0.379
-
Vemuru S, Helmkamp L, Adams M, Colborn K, Parris H, Huynh V, Higgins M, Christian N, Ahrendt G, Baurle E, Lee C, Kim S, Matlock D, Cumbler E, Tevis S. Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2024 Oct; 31(11):7597-7606.
Score: 0.371
-
O'Brien E, Ludwigson A, Vemuru S, Higgins M, Hampanda K, Adams M, Wolverton D, Sams S, Taft N, Miles R, Lin CT, Cumbler E, Tevis S. Interpretation of immediately released health information: Informing patient medical education in breast oncology. Am J Surg. 2025 Jan; 239:115853.
Score: 0.371
-
Jeon JH, Adams M, Higgins MG, Vemuru SR, Ludwigson AM, Huynh V, Baurle E, Rojas K, Matlock DD, Lee C, Kim S, Tevis S. Breast Cancer Surgery: A Qualitative Exploration of Concerns Over Time. J Surg Res. 2024 Aug; 300:272-278.
Score: 0.368
-
McCranie A, Lee AD, Leonard L, Vemuru S, Huynh V, D'Angelo J, D'Angelo AL, Ahrendt G, Kaoutzanis C, Fisher C, Gleisner A, Meguid C, Schulick R, Del Chiaro M, Tevis S. Exploration of Patient Retention in Seeking a Second Opinion: A Retrospective Cohort Study. J Surg Res. 2025 Feb; 306:588-603.
Score: 0.368
-
Ludwigson A, Huynh V, Vemuru S, Romandetti K, Fisher C, Coons HL, Pettigrew J, Hampanda K, Kaoutzanis C, Ahrendt G, Afghahi A, Stewart C, Tevis S. Characterizing informational needs and information seeking behavior of patients with breast cancer. Am J Surg. 2024 01; 227:100-105.
Score: 0.352
-
Mott NM, Huynh V, Vemuru S, Parris HJ, Colborn K, Ahrendt G, Christian N, Kim S, Matlock DD, Cumbler E, Tevis SEA. Barriers and facilitators to measuring patient reported outcomes in an academic breast cancer clinic: An application of the RE-AIM framework. Am J Surg. 2024 02; 228:180-184.
Score: 0.350
-
Vemuru SR, Bronsert M, Vossler K, Huynh VD, Beaty L, Ahrendt G, Arruda J, Kaoutzanis C, Rojas KE, Bozzuto L, Kim S, Tevis SE. Postoperative Outcomes After Staged Versus Coordinated Breast Surgery and Bilateral Salpingo-Oophorectomy. Ann Surg Oncol. 2023 Sep; 30(9):5667-5680.
Score: 0.345
-
Vemuru S, Huang J, Colborn K, Yoon Y, Huynh V, Leonard L, Ahrendt G, Christian N, Afghahi A, McLemore L, Sams S, Tevis S. Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy. Breast Cancer Res Treat. 2023 Jul; 200(2):247-256.
Score: 0.343
-
Vemuru S, Tevis SE. ASO Author Reflections: In Which Patients Should We Coordinate Breast Surgery and Bilateral Salpingo-oophorectomy? Ann Surg Oncol. 2023 09; 30(9):5681-5682.
Score: 0.343
-
Vemuru SR, Tevis SE. Operative Management in Stage IV Breast Cancer. Surg Clin North Am. 2023 Feb; 103(1):93-106.
Score: 0.329
-
Neilson T, Huynh V, Macdonald A, Romandetti K, Ahrendt G, Hampanda K, Kim SP, Tevis SE. Financial Toxicity of Breast Cancer Care: The Patient Perspective Through Surveys and Interviews. J Surg Res. 2023 01; 281:122-129.
Score: 0.327
-
Huynh V, Vemuru S, Hampanda K, Pettigrew J, Fasano M, Coons HL, Rojas KE, Afghahi A, Ahrendt G, Kim S, Matlock DD, Tevis SE. No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer. Ann Surg Oncol. 2022 Oct; 29(10):6238-6251.
Score: 0.324
-
Vemuru S, Lee CN, Tevis SE. Association of Breast-Conserving Therapy With Measures of Long-term Quality of Life Compared With Mastectomy and Reconstruction. JAMA Surg. 2022 06 01; 157(6):e220637.
Score: 0.321
-
Tevis SE, Hunt KK, Miranda RN, Lange C, Pinnix CC, Iyer S, Butler CE, Clemens MW. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients. Ann Surg. 2022 01 01; 275(1):e245-e249.
Score: 0.311
-
Ludwigson A, Huynh V, Myers S, Hampanda K, Christian N, Ahrendt G, Romandetti K, Tevis S. Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed Methods Study. Ann Surg Oncol. 2022 Mar; 29(3):1649-1657.
Score: 0.311
-
Huynh V, Colborn K, Smith S, Bonnell LN, Ahrendt G, Christian N, Kim S, Matlock DD, Lee C, Tevis SE. Early Trajectories of Patient Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy. Ann Surg Oncol. 2021 Oct; 28(10):5677-5685.
Score: 0.302
-
Huynh V, Yang J, Bronsert M, Ludwigson A, Ahrendt G, Kim S, Matlock DD, Cohen J, Hampanda K, Tevis SE. Choosing Between Mastectomy and Breast-Conserving Therapy: Is Patient Distress an Influencing Factor? Ann Surg Oncol. 2021 Dec; 28(13):8679-8687.
Score: 0.300
-
Su M, Huynh V, Bronsert M, Su E, Goode J, Lock A, Banden S, Ahrendt G, Afghahi A, Arruda J, Tevis S. Longitudinal Risk Management for Patients with Increased Risk for Breast Cancer. J Surg Res. 2021 10; 266:421-429.
Score: 0.299
-
Huynh V, Tevis S. Surgical management of invasive lobular carcinoma: Is less more? Am J Surg. 2021 01; 221(1):30-31.
Score: 0.284
-
Ludwigson A, Huynh V, Bronsert M, Sloan K, Murphy C, Christian N, Jaiswal K, Ahrendt G, Tevis SE. A screening tool identifies high distress in newly diagnosed breast cancer patients. Surgery. 2020 11; 168(5):935-941.
Score: 0.280
-
Kovar A, Bronsert M, Jaiswal K, Murphy C, Wolverton D, Ahrendt G, Tevis S. The Waiting Game: How Long Are Breast Cancer Patients Waiting for Definitive Diagnosis? Ann Surg Oncol. 2020 Oct; 27(10):3641-3649.
Score: 0.277
-
Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol. 2019 Mar; 26(3):815-820.
Score: 0.252
-
Tevis SE, James TA, Kuerer HM, Pusic AL, Yao KA, Merlino J, Dietz J. Patient-Reported Outcomes for Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10):2839-2845.
Score: 0.244
-
Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol. 2018 Oct; 25(10):2932-2938.
Score: 0.244
-
Thomas MB, Ghaffar SA, Kadri H, Quinn CM, Leonard LD, Mott NM, Franco SR, Assumpção LR, Ahrendt G, Tevis SEA, Christian N, Widner J, Heelan AA, Gleisner AL. Multi-level factors drive use of sentinel lymph node biopsy in older women with early-stage breast cancer. Breast Cancer Res Treat. 2025 Nov; 214(1):37-48.
Score: 0.100
-
Flanagan MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, Gallagher KK, Jakub JW, Tevis SEA, Verdial FC, Zhang JQ, Elmore LC, Mukhtar RA, Brennan M, Lillie M, Gibson TC, Verosky A, Plichta JK, Rosenberger LH. A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer. Ann Surg Oncol. 2025 Aug; 32(8):5551-5562.
Score: 0.098
-
Swafford EP, Anantha S, Davis J, Heath R, Draper A, Tevis S, Goel N, Kesmodel SB, Rojas KE. Lumpectomy Patients are at Highest Risk for Opioid Overprescription: A Comparison Between Practice Patterns and OPEN National Guidelines. Ann Surg Oncol. 2025 Apr; 32(4):2585-2593.
Score: 0.096
-
Northrop A, Christofferson A, Umashankar S, Melisko M, Castillo P, Brown T, Heditsian D, Brain S, Simmons C, Hieken T, Ruddy KJ, Mainor C, Afghahi A, Tevis S, Blaes A, Kang I, Asare A, Esserman L, Hershman DL, Basu A. Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer. J Am Med Inform Assoc. 2025 01 01; 32(1):172-180.
Score: 0.096
-
Gu JZ, Baird GL, Escamilla Guevara A, Sohn YJ, Lydston M, Doyle C, Tevis SEA, Miles RC. A systematic review and meta-analysis of English language online patient education materials in breast cancer: Is readability the only story? Breast. 2024 Jun; 75:103722.
Score: 0.091
-
Leonard LD, de Araujo TB, Quinn C, Thomas MB, Beaty L, Mott NM, Colborn K, Heelan AA, Tevis SEA, Christian N, Arhendt G, Gleisner AL. De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer. Ann Surg Oncol. 2023 Sep; 30(9):5692-5702.
Score: 0.086
-
Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou T. Innovation in Breast Surgery: Practical and Ethical Considerations. Ann Surg Oncol. 2022 Oct; 29(10):6144-6150.
Score: 0.081
-
Gleisner AL, Moss A, Friedman C, Suresh K, Grunwald G, Torphy RJ, Leonard LD, Colborn K, Ahrendt G, Tevis S, Christian N, Abud VL, de Araujo TB, Beaty LE, Thieu D, Glorioso TJ, Kim S, Daugherty S. De-implementation of Axillary Dissection in Women With Breast Cancer is Largely Driven By Site-level Contextual Effects. Ann Surg. 2022 12 01; 276(6):e923-e931.
Score: 0.072
-
Singh P, Tevis SE, Hall CS, Meas S, Hwang RF, Lucci A. Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score. Breast Cancer Res Treat. 2020 Dec; 184(3):683-687.
Score: 0.071
-
Tevis SE, Hunt KK, Miranda RN, Lange C, Butler CE, Clemens MW. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population. Aesthet Surg J. 2019 09 13; 39(10):1065-1070.
Score: 0.066
-
Park KU, Weiss A, Rosso K, Yi M, Hunt K, Kuerer H, Hanson SE, Candelaria R, Tevis S, Thompson A. Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers. Ann Surg Oncol. 2020 Feb; 27(2):367-372.
Score: 0.066
-
Garoosi K, Kalia N, Adepoju J, Escobar-Domingo MJ, Horstman C, Kahan R, Fitzpatrick Q, Ahn YJ, Park JB, Grobman B, Lee D, Shenaq DS, Kurlander D, Raj M, Tevis S, Arruda J, Winocour J, Kokosis G, Lee BT, Mathes DW, Kaoutzanis C. Post-operative complications in combined versus staged breast reconstruction and risk-reducing gynecologic surgeries: A multi-institution multi-surgeon analysis. J Plast Reconstr Aesthet Surg. 2025 Aug; 107:258-266.
Score: 0.025
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|